Semaphorins and Neuropilins are regulators of tumor angiogenesis.

被引：0
|
作者：
Klagsbrun, M [1 ]
机构：
[1] Childrens Hosp, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9170S / 9170S
页数：1
相关论文
共 50 条
  • [1] Role of neuropilins and semaphorins in angiogenesis and cancer
    Kreuter, M
    Bielenberg, D
    Hida, Y
    Hida, K
    Klagsbrun, M
    [J]. ANNALS OF HEMATOLOGY, 2002, 81 : S74 - S74
  • [2] Neuropilins and semaphorins - from angiogenesis to autoimmunity
    Vadasz, Z.
    Attias, D.
    Kessel, A.
    Toubi, E.
    [J]. AUTOIMMUNITY REVIEWS, 2010, 9 (12) : 825 - 829
  • [3] Semaphorins and tumor angiogenesis
    Guido Serini
    Federica Maione
    Enrico Giraudo
    Federico Bussolino
    [J]. Angiogenesis, 2009, 12 (2) : 195 - 195
  • [4] Semaphorins and tumor angiogenesis
    Guido Serini
    Federica Maione
    Federico Bussolino
    [J]. Angiogenesis, 2009, 12 : 187 - 193
  • [5] Semaphorins and tumor angiogenesis
    Serini, Guido
    Maione, Federica
    Bussolino, Federico
    Giraudo, Enrico
    [J]. ANGIOGENESIS, 2009, 12 (02) : 187 - 193
  • [6] Neuropilins as receptors for semaphorins
    不详
    [J]. NEUROSCIENTIST, 1999, 5 (02): : 68 - 68
  • [7] Monocytes and tumor angiogenesis.
    De Palma, Michele
    Venneri, Mary Anna
    Galli, Rossella
    Pucci, Ferdinando
    Naldini, Luigi
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [8] Semaphorins in Angiogenesis and Tumor Progression
    Neufeld, Gera
    Sabag, Adi D.
    Rabinovicz, Noa
    Kessler, Ofra
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (01):
  • [9] Hypoxia signaling and tumor angiogenesis.
    Berra, E
    Dayan, F
    Ginouves, A
    Mazure, N
    Roux, D
    Trastour, C
    Pouyssegur, J
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2778S - 2779S
  • [10] The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
    Gera Neufeld
    Ofra Kessler
    [J]. Nature Reviews Cancer, 2008, 8 : 632 - 645
12345